| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.095 | 0.1 |